Achillion Pharmaceuticals, Inc.
(NASDAQ : ACHN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.41%73.970.9%$407.36m
AMGNAmgen Inc.
0.32%202.981.2%$406.21m
CELGCelgene Corporation
-0.41%87.251.2%$335.52m
BIIBBiogen Inc.
0.53%338.661.2%$283.70m
ILMNIllumina, Inc.
-0.77%348.183.5%$249.42m
REGNRegeneron Pharmaceuticals, Inc.
-1.16%383.822.6%$210.58m
EXASExact Sciences Corporation
0.47%73.1025.3%$193.16m
VRTXVertex Pharmaceuticals Incorporated
-0.55%176.151.9%$159.75m
SRPTSarepta Therapeutics, Inc.
-0.39%152.9816.4%$125.90m
AAgilent Technologies, Inc.
0.44%69.231.5%$121.57m
ALXNAlexion Pharmaceuticals, Inc.
0.55%121.482.0%$111.46m
VKTXViking Therapeutics, Inc.
6.22%20.670.9%$94.21m
ALNYAlnylam Pharmaceuticals, Inc
-0.43%93.359.7%$93.70m
NKTRNektar Therapeutics
-2.62%56.805.6%$93.21m
BMRNBioMarin Pharmaceutical Inc.
-0.65%98.924.4%$93.05m

Company Profile

Achillion Pharmaceuticals, Inc. engages in the discovery and development of small molecule drug therapies for immune system disorders. It offers its propriety platform of potent and specific complement factor D inhibitors for AP-mediated diseases. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.